After a period of exponential growth and record-breaking market indicators throughout 2020 and 2021, 2022 marked a period of stabilization for Greater Boston’s life sciences market. While the momentum continued throughout the first half of the year, activity slowed during the third and fourth quarters as demand cooled.
While the market will face headwinds in the coming year amidst an uncertain economic climate, Greater Boston is well-positioned to remain a top-tier life sciences market.
Boston Biostatus January 2023
Riley McMullan • 1/31/2023
Insights in your Inbox
Subscribe to the latest local market research, insights and analysis from Cushman & Wakefield across the United States.
Subscribe
Related Insights
Research
Life Sciences Update: September 2023
The hypergrowth experienced by the life sciences sector early in the pandemic has given way to a much more normalized environment today—with funding in the life sciences space having declined 26% year-over-year (YoY).
Sandy Romero • 9/28/2023
Article
Does your building qualify for a life sciences conversion?
Interest in converting assets for life sciences use is growing amongst building owners. Cushman & Wakefield’s Project & Development Services team developed basic building performance criteria based on the minimum standards that life sciences companies typically require.
Eric Giles • 7/18/2023
Related Industries
Life Sciences
Our life sciences real estate experts drive customized, dynamic solutions for investors, owners, developers and occupiers within the quickly evolving life sciences sector.
Learn More